BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8752897)

  • 1. IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2.
    Chakrabarti D; Hultgren B; Stewart TA
    J Immunol; 1996 Jul; 157(2):522-8. PubMed ID: 8752897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes.
    Guerder S; Eynon EE; Flavell RA
    J Immunol; 1998 Sep; 161(5):2128-40. PubMed ID: 9725204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular adhesion molecule-1 is necessary but not sufficient to activate CD4+ T cells. Discovery of a novel costimulator on kidney tubule cells.
    Hagerty DT
    J Immunol; 1996 May; 156(10):3652-9. PubMed ID: 8621899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells.
    Roth R; Nakamura T; Mamula MJ
    J Immunol; 1996 Oct; 157(7):2924-31. PubMed ID: 8816398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb.
    Chowdhury SA; Nagata M; Yamada K; Nakayama M; Chakrabarty S; Jin Z; Kotani R; Yokono K
    Kobe J Med Sci; 2002 Dec; 48(5-6):167-75. PubMed ID: 12657834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.
    Skak K; Haase C; Michelsen BK
    Eur J Immunol; 2005 Sep; 35(9):2583-90. PubMed ID: 16078275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice.
    Van Parijs L; Sethna MP; Schweitzer AN; Borriello F; Sharpe AH; Abbas AK
    J Immunol; 1997 Dec; 159(11):5336-44. PubMed ID: 9548473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling.
    Tam RC; Lim C; Bard J; Pai B
    J Immunol; 1999 Oct; 163(7):3709-17. PubMed ID: 10490966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies.
    Herold KC; Vezys V; Gage A; Montag AG
    Cell Immunol; 1994 Sep; 157(2):489-500. PubMed ID: 7915204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone.
    Kato T; Morokata T; Igarashi O; Yee ST; Inobe M; Uede T; Azuma M; Okumura K; Nariuchi H
    Cell Immunol; 1997 Feb; 176(1):50-8. PubMed ID: 9070317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation.
    Zuckerman LA; Pullen L; Miller J
    J Immunol; 1998 Apr; 160(7):3259-68. PubMed ID: 9531282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
    Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH
    J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
    Subauste CS; de Waal Malefyt R; Fuh F
    J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 and IFN-gamma dependent T cell activation by human bronchial epithelial cells.
    Tanaka H; Maeda K; Nakamura Y; Azuma M; Yanagawa H; Sone S
    J Med Invest; 2001 Feb; 48(1-2):109-17. PubMed ID: 11286011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86).
    Ushio H; Tsuji RF; Szczepanik M; Kawamoto K; Matsuda H; Askenase PW
    J Immunol; 1998 Mar; 160(5):2080-8. PubMed ID: 9498744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen.
    Soldevila G; Geiger T; Flavell RA
    J Immunol; 1995 Dec; 155(12):5590-600. PubMed ID: 7499842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.